Menu
Recruiting NCT05192876

Analysis of Outcomes and Adverse Events of Patients Undergoing Radiation Therapy

Observational Radiotherapy; Adverse Effect Radiotherapy; Complications Quality of Life

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Radiotherapy.
Who it may be relevant to
Registry conditions: Radiotherapy; Adverse Effect, Radiotherapy; Complications, Quality of Life. Basic parameters: 16 years — 105 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Switzerland
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Analysis of Outcomes and Adverse Events of Patients Undergoing Radiation Therapy. Quality Control Using Data Base of Patient Records 2000-2025

Overview

Analysis of outcomes and adverse events of patients undergoing radiation therapy. Quality control using data base of patient records 2000-2025

Detailed description

What are the findings of the systematic recording and analysis of the outcomes and adverse events of radiotherapy, and how do these findings improve radiotherapy for future patients?

The goals of the systematic collection and analysis of patient-related personal data include:

* Quality assurance and showing where the quality can be improved * Recording the outcomes and side effect profile of radiotherapy and adapting to prevent serious side effects in the future * Presentation and publication as part of the clinical research program at the Institute for Radio-Oncology of the Winterthur Cantonal Hospital

Interventions

  • Radiation Radiotherapy
    Outcomes and adverse events using radiation therapy

Primary outcome measures

  • Overall survival (OS) and progression free survival (PFS) analysis after radiation therapy [Time frame: 25 years]
  • Analysis of risk factors influencing outcome after radiation therapy [Time frame: 25 years]
Secondary outcome measures (1)
  • Number of patients with acute and late adverse events after radiation therapy [Time frame: 25 years]

Eligibility criteria

Inclusion criteria

  • Patients who are being treated with radiotherapy at the Department of Radiation Oncology at the Winterthur Cantonal Hospital

Exclusion criteria

  • No radiotherapy at the Department of Radiation Oncology at the Winterthur Cantonal Hospital <16 years,> 105 years

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Study design

Observational model
Cohort

Study locations

Switzerland · 1 center
  • Kantonsspital Winterthur — Winterthur

Publications

  • Windisch P, Becker I, Tang H, Schroder C, Buchali A, Aebersold DM, Zwahlen DR, Forster R, Shelan M. Converting between the International Prostate Symptom Score (IPSS) and the Expanded Prostate Cancer Index Composite (EPIC) urinary subscales: modeling and external validation. BMC Urol. 2024 Feb 3;24(1):28. doi: 10.1186/s12894-024-01421-y. PMID 38310268

Identifiers

NCT: NCT05192876 · BASEC-Nr. 2020-02112

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗